Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Combination therapy for cancer using bromodomain and extra-terminal (BET) protein inhibitors

Combination therapy for cancer using bromodomain and extra-terminal (BET) protein inhibitors

US Patent 11446309 · Granted Sep 20, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compounds and methods for treating cancer2025
Therapeutic targeting of KMT2D mutant lung squamous cell carcinoma through RTK-R2025
Chromobox protein inhibitors and uses thereof2024
Compositions and methods for selective protein degradation2024
Combination therapy for treatment of LKB1 deficient cancers2024
Calmodulin inhibitors, Chk2 inhibitors and RSK inhibitors for the treatment of r2024
Compositions and methods of modulating anti-tumor immunity2024
Compounds and methods for treating cancer2023
Compositions, kits, and methods for the diagnosis, prognosis, monitoring, treatm2023
Anti-galectin-1 (Gal1) monoclonal antibodies and fragments thereof for neutraliz2023
Mechanism of resistance to bet bromodomain inhibitors2023
Tumor suppressor and oncogene biomarkers predictive of anti-immune checkpoint in2023